Browsing: Pharma

The union at fast-growing South Korean CDMO Samsung Biologics launched a planned general strike on…

An unexpected missed interim study in ivonecicimab’s high-profile Harmoni-3 study has sent Summit Therapeutics’ stock…

Four years after winning FDA approval for Overity to treat major depressive disorder (MDD), Axum…

Shortly after paying $75 million up front for Corstasis Therapeutics and its congestive heart failure…

This is a pivotal year for Ionis Pharmaceuticals, a pioneer in RNA therapeutics. After moving…

Sun Pharma will acquire Organon for $11.75 billion. Astellas Pharma predicts that sales of Xtandy…

The pharmaceutical sector faces patent cliffs and rising costs. Explore 2026 trends in AI drug discovery, gene therapy, biopharma manufacturing, clinical pipelines, and FDA approvals to drive efficiency and innovation.

Amgen CEO Robert Bradway has declared that 2026 will be a “breakthrough year” for the…

Verastem Oncology has launched a marketing campaign for its co-packaged cancer drug to promote its…

Bristol-Myers Squibb’s growth portfolio is on track to offset declines in legacy products, even as…